OPRX
Income statement / Annual
Last year (2023), OptimizeRx Corporation's total revenue was $71.52 M,
an increase of 14.53% from the previous year.
In 2023, OptimizeRx Corporation's net income was -$17.57 M.
See OptimizeRx Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$71.52 M
|
$62.45 M
|
$61.29 M
|
$43.31 M
|
$24.60 M
|
$21.21 M
|
$12.13 M
|
$7.75 M
|
$7.22 M
|
$6.50 M
|
| Cost of Revenue |
$28.62 M |
$23.48 M |
$25.65 M |
$19.21 M |
$9.16 M |
$9.00 M |
$6.17 M |
$3.41 M |
$3.62 M |
$3.22 M |
| Gross Profit |
$42.90 M |
$38.97 M |
$35.64 M |
$24.11 M |
$15.44 M |
$12.21 M |
$5.95 M |
$4.34 M |
$3.60 M |
$3.28 M |
| Gross Profit Ratio |
0.6 |
0.62 |
0.58 |
0.56 |
0.63 |
0.58 |
0.49 |
0.56 |
0.5 |
0.5 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$1.08 M
|
$2.67 M
|
$675,660.00
|
$1.01 M
|
$398,396.00
|
$290,371.00
|
$189,566.00
|
| General & Administrative
Expenses |
$58.02 M
|
$49.24 M
|
$33.19 M
|
$24.16 M
|
$17.85 M
|
$11.71 M
|
$7.76 M
|
$4.94 M
|
$3.27 M
|
$3.37 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$1.03 M
|
$615,923.00
|
$709,006.00
|
$299,955.00
|
$207,062.00
|
$296,997.00
|
$47,927.00
|
$87,201.00
|
| Selling, General &
Administrative Expenses |
$58.02 M
|
$49.24 M
|
$33.19 M
|
$24.16 M
|
$17.85 M
|
$11.71 M
|
$7.76 M
|
$5.24 M
|
$3.32 M
|
$3.45 M
|
| Other Expenses |
$11.28 M |
$2.02 M |
$2.09 M |
$994,751.00 |
-$1.39 M |
$449,002.00 |
$324,551.00 |
$235,284.00 |
$583,950.00 |
$264,340.00 |
| Operating Expenses |
$69.30 M |
$51.26 M |
$35.28 M |
$26.24 M |
$19.13 M |
$12.03 M |
$8.08 M |
$5.87 M |
$4.20 M |
$3.91 M |
| Cost And Expenses |
$97.92 M |
$74.74 M |
$60.93 M |
$45.45 M |
$28.29 M |
$21.03 M |
$14.26 M |
$9.28 M |
$7.82 M |
$7.13 M |
| Interest Income |
$2.19 M |
$852,298.00 |
$16,979.00 |
$68,582.00 |
$288,028.00 |
$46,212.00 |
$25,937.00 |
$42,309.00 |
$2,267.00 |
$935.00 |
| Interest Expense |
$1.45 M |
$852,298.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$2.40 M
|
$2.02 M
|
$2.09 M
|
$2.08 M
|
$1.28 M
|
$316,502.00
|
$324,551.00
|
$235,284.00
|
$333,950.00
|
$264,340.00
|
| EBITDA |
-$21.31 M
|
-$9.42 M
|
$2.33 M
|
-$59,431.00
|
-$2.76 M
|
$1.24 M
|
-$1.81 M
|
-$1.30 M
|
-$261,190.00
|
-$761,053.00
|
| EBITDA Ratio |
-0.3 |
-0.16 |
0.04 |
0 |
-0.07 |
0.02 |
-0.15 |
-0.16 |
-0.04 |
-0.06 |
| Operating Income Ratio
|
-0.37
|
-0.2
|
0.01
|
-0.04
|
-0.15
|
0.01
|
-0.18
|
-0.2
|
-0.08
|
-0.16
|
| Total Other
Income/Expenses Net |
$1.24 M
|
$852,298.00
|
$16,979.00
|
-$71,808.00
|
-$346,972.00
|
$46,212.00
|
$25,937.00
|
$42,309.00
|
$2,267.00
|
$935.00
|
| Income Before Tax |
-$25.16 M |
-$11.44 M |
$378,079.00 |
-$2.21 M |
-$4.04 M |
$226,344.00 |
-$2.10 M |
-$1.54 M |
-$595,140.00 |
-$1.03 M |
| Income Before Tax Ratio
|
-0.35
|
-0.18
|
0.01
|
-0.05
|
-0.16
|
0.01
|
-0.17
|
-0.2
|
-0.08
|
-0.16
|
| Income Tax Expense |
-$7.60 M |
-$852,298.00 |
$104,150.00 |
$176,613.00 |
-$897,960.00 |
$46,212.00 |
$0.00 |
$0.00 |
$2,267.00 |
$0.00 |
| Net Income |
-$17.57 M |
-$10.59 M |
$273,929.00 |
-$2.38 M |
-$3.14 M |
$226,344.00 |
-$2.10 M |
-$1.54 M |
-$595,140.00 |
-$1.03 M |
| Net Income Ratio |
-0.25 |
-0.17 |
0 |
-0.06 |
-0.13 |
0.01 |
-0.17 |
-0.2 |
-0.08 |
-0.16 |
| EPS |
-1.03 |
-0.6 |
0.0159 |
-0.16 |
-0.23 |
0.02 |
-0.21 |
-0.16 |
-0.0727 |
-0.14 |
| EPS Diluted |
-1.03 |
-0.6 |
0.0155 |
-0.16 |
-0.23 |
0.0191 |
-0.21 |
-0.16 |
-0.0727 |
-0.14 |
| Weighted Average Shares
Out |
$17.12 M
|
$17.78 M
|
$17.23 M
|
$14.83 M
|
$13.39 M
|
$11.32 M
|
$9.82 M
|
$9.90 M
|
$8.19 M
|
$7.46 M
|
| Weighted Average Shares
Out Diluted |
$17.12 M
|
$17.78 M
|
$17.69 M
|
$14.83 M
|
$13.39 M
|
$11.86 M
|
$9.82 M
|
$9.90 M
|
$8.19 M
|
$7.46 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
